An interventional study of Percutaneous fixation of acute Scaphoid fractures in Scaphoid Fracture, sponsored by Sohag University. Completed at 1 site in Egypt. Open to participants aged 16 Years to 60 Years. Per ClinicalTrials.gov, last updated 2022-06-21.
Sponsored by Sohag University · Not applicable, Interventional, and Treatment
Percutaneous Trans-trapezial fixation of acute Scaphoid fractures by Herbert screw
Aim of the work:
To assessment outcomes of percutaneous Trans-trapezial fixation of acute scaphoid fracture.
Operative Technique:
Anesthesia: carried out under general anesthesia or brachial plexus block and under tourniquet control.
Position: supine. Approach: Percutaneous Trans-trapezial fixation of acute Scaphoid fracture. Recording any intraoperative complication that may affect the result.
Postoperative Follow Up:
Short arm circular cast including the thumb will be applied. After 3 weeks, cast will be removed and exercises will start.
Sohag University is the lead sponsor of 1,220 studies on the registry; 629 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
group (1) who are complaining of acute scaphoid fractures,we will do percutaneous trans trapezial fixation of scaphoid by Herbert screw.Short arm circular cast including the thumb will be applied. After 3 weeks, cast will be removed and exercises will start.
Procedure: Percutaneous fixation of acute Scaphoid fractures
Percutaneous Trans-trapezial fixation of acute Scaphoid fractures by Herbert screw
Change of wrist power
Modified Mayo wrist score
Time frame: Up to 18 months
This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.